Mycophenolate mofetil is associated with comparable treatment outcomes to methotrexate among patients with juvenile localized scleroderma.
Atomic force microscopy (BioAFM) drives innovation in cosmetics and healthcare, ensuring product efficacy through precise ...
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company ...
Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions with significant ...
Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions with significant unmet medical need - - QRX003 lotion (4%) currently being ...
This may sound daft but for the past 18 months I've suffered from a very cold nose - even when the rest of my body is warm. It's quite painful and I suffer during cold weather.
Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products The agreement will allow ...
US Weekly on MSN
‘RuPaul's Drag Race' Stars' Health Scares and Tragedies
RuPaul’s Drag Race’s universe of vibrant and talented drag queens has endured numerous heartbreaking losses and health scares ...
A 55-year-old man developed painful swelling that doctors later thought was arthritis. Subtle clues revealed something more ...
Detailed price information for Quoin Pharmaceuticals Ltd ADR (QNRX-Q) from The Globe and Mail including charting and trades.
RIT biomedical engineering researchers identify a protein that can reduce fibrosis and slow disease progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results